Results 181 to 190 of about 8,213 (208)

Outbreak of herpangina associated with coxsackievirus B3 infection

The Pediatric Infectious Disease Journal, 1989
An outbreak of acute febrile illness was observed in summer, 1987, in a welfare home in which 31 healthy infants were accommodated. Within a 5-day period 25 infants (81%) acquired a febrile illness. Coxsackievirus B3 was isolated from 16 (64%) of 25 throat swabs.
T, Nakayama, T, Urano, M, Osano, Y, Hayashi, S, Sekine, T, Ando, S, Makinom   +6 more
openaire   +2 more sources

Role of MIP-2 in Coxsackievirus B3 Myocarditis

Journal of Molecular and Cellular Cardiology, 2000
Interleukin-8 (IL-8) is a chemotactic cytokine for neutrophils and lymphocytes. Macrophage inflammatory protein-2 (MIP-2) is a murine counterpart of IL-8. The present study was performed to determine the role of MIP-2 in murine myocarditis. We examined (1) the MIP-2 producing activity of Coxsackievirus B3 (CB3)-infected cultured macrophages, (2) serial
C, Kishimoto, H, Kawamata, S, Sakai, H, Shinohara, H, Ochiai   +4 more
openaire   +2 more sources

Extracellular Matrix Remodeling in Coxsackievirus B3 Myocarditis

Clinical Immunology and Immunopathology, 1997
The connective tissue abnormality in relation to T lymphocytes was investigated in murine myocarditis. Inbred BALB/c-nu/+ (euthymic and normal T cell function) and BALB/c-nu/nu (athymic and T cell deficient) mice were inoculated with coxsackievirus B3 (CB3). Hearts were stained with hematoxylin-eosin, Malloryazan, and silver impregnation, for reticulin
C, Kishimoto, M, Kitazawa, Y, Hiraoka, H, Takada   +3 more
openaire   +2 more sources

Nucleotide differences of coxsackievirus B3 and chronic myocarditis

Heart and Vessels, 2014
The in vivo mechanisms in chronic myocarditis remain unclear. The aim of the current study was to clarify the genomic difference of amyocarditic (CB3O) and myocarditic (CB3M) coxsackievirus B3 (CB3) and the pathogenesis of in vivo mechanisms in chronic myocarditis.
Chiharu, Kishimoto, Nami, Takamatsu, Hiroshi, Ochiai, Kagemasa, Kuribayashi   +3 more
openaire   +2 more sources

Coxsackievirus B3 targets TFEB to disrupt lysosomal function

Autophagy, 2021
Yasir Mohamud, Yuan Chao Xue, Huitao Liu   +2 more
exaly  

Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating

Cell Host and Microbe, 2021
Longfa Xu, Qingbing Zheng, Rui Zhu
exaly  

Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.

Nature structural biology, 2001
Group B coxsackieviruses (CVB) utilize the coxsackievirus-adenovirus receptor (CAR) to recognize host cells. CAR is a membrane protein with two Ig-like extracellular domains (D1 and D2), a transmembrane domain and a cytoplasmic domain. The three-dimensional structure of coxsackievirus B3 (CVB3) in complex with full length human CAR and also with the ...
Y, He, P R, Chipman, J, Howitt, C M, Bator, M A, Whitt, T S, Baker, R J, Kuhn, C W, Anderson, P, Freimuth, M G, Rossmann   +9 more
openaire   +1 more source

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

Cell Host and Microbe, 2020
Maozhou He, Longfa Xu, Qingbing Zheng
exaly  

An outbreak of a novel recombinant Coxsackievirus A4 in a kindergarten, Shandong province, China, 2021

Emerging Microbes and Infections, 2022
Xiufan Liu, Mengyuan Cao, Weijia Xing
exaly  

Protective Role for Interferon-β in Coxsackievirus B3 Infection

Circulation, 2004
Eleanor N Fish
exaly